Testing effectiveness (Phase 2)Study completedNCT02762084
What this trial is testing
Trial of Patidegib Gel 2%, 4%, and Vehicle to Decrease the Number of Surgically Eligible Basal Cell Carcinomas in Gorlin Syndrome Patients
Who this might be right for
Basal Cell Nevus Syndrome
PellePharm, Inc. 17